Teleflex Inc financial data

Symbol
TFX on NYSE
Industry
Surgical & Medical Instruments & Apparatus
Location
550 E Swedesford Rd, Suite 400, Wayne, PA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-K - Q4 2024 - Feb 28, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 244 % -11.2%
Quick Ratio 105 % -2.72%
Debt-to-equity 65.6 % -4.79%
Return On Assets 0.94 % -80.9%
Operating Margin 4.96 % -70.9%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 46.4M shares -1.56%
Entity Public Float 4.28B USD -24.1%
Common Stock, Value, Issued 48.1M USD +0.1%
Weighted Average Number of Shares Outstanding, Basic 46.8M shares -0.31%
Weighted Average Number of Shares Outstanding, Diluted 47.1M shares -0.44%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 3.05B USD +2.45%
Research and Development Expense 162M USD +4.74%
Operating Income (Loss) 151M USD -70.2%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 75.5M USD -82.6%
Income Tax Expense (Benefit) 5.32M USD -93%
Net Income (Loss) Attributable to Parent 69.7M USD -80.4%
Earnings Per Share, Basic 1.49 USD/shares -80.3%
Earnings Per Share, Diluted 1.48 USD/shares -80.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 290M USD +30.2%
Accounts Receivable, after Allowance for Credit Loss, Current 459M USD +3.61%
Inventory, Net 600M USD -4.17%
Assets, Current 1.47B USD +4.53%
Deferred Income Tax Assets, Net 11.4M USD +68.6%
Property, Plant and Equipment, Net 503M USD +4.78%
Operating Lease, Right-of-Use Asset 109M USD -11.8%
Intangible Assets, Net (Excluding Goodwill) 2.27B USD -9.32%
Goodwill 2.63B USD -9.67%
Other Assets, Noncurrent 103M USD +3.72%
Assets 7.1B USD -5.77%
Accounts Payable, Current 141M USD +6.64%
Employee-related Liabilities, Current 151M USD +3.23%
Accrued Liabilities, Current 143M USD -2.53%
Liabilities, Current 649M USD +7.02%
Deferred Income Tax Liabilities, Net 391M USD -14.3%
Operating Lease, Liability, Noncurrent 99.2M USD -10.9%
Other Liabilities, Noncurrent 102M USD -37%
Liabilities 2.82B USD -8.79%
Accumulated Other Comprehensive Income (Loss), Net of Tax -317M USD -0.72%
Retained Earnings (Accumulated Deficit) 4.12B USD +0.15%
Stockholders' Equity Attributable to Parent 4.28B USD -3.67%
Liabilities and Equity 7.1B USD -5.77%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Financing Activities -71.4M USD +23.7%
Net Cash Provided by (Used in) Investing Activities -24.8M USD -13.3%
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 48.1M shares +0.1%
Common Stock, Par or Stated Value Per Share 1 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 14.6M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 328M USD +47%
Deferred Tax Assets, Valuation Allowance 88.4M USD -7.66%
Operating Lease, Liability 117M USD -10.9%
Depreciation 15.9M USD -12.9%
Payments to Acquire Property, Plant, and Equipment 38.4M USD +76%
Lessee, Operating Lease, Liability, to be Paid 137M USD -10.3%
Property, Plant and Equipment, Gross 1.11B USD +5.74%
Lessee, Operating Lease, Liability, to be Paid, Year Two 23.3M USD +2.88%
Lessee, Operating Lease, Liability, to be Paid, Year One 22M USD -8.32%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure 0%
Deferred Income Tax Expense (Benefit) -58.3M USD -2886%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 20.4M USD -6.91%
Lessee, Operating Lease, Liability, to be Paid, Year Three 21.9M USD +0.77%
Preferred Stock, Shares Authorized 500K shares 0%
Unrecognized Tax Benefits 1.02M USD -49.5%
Lessee, Operating Lease, Liability, to be Paid, Year Four 20.3M USD +0.15%
Additional Paid in Capital 781M USD +4.2%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 50.1M USD +20.6%
Deferred Tax Assets, Net of Valuation Allowance 141M USD -8.43%
Interest Expense 92.8M USD +35.5%